Molina Healthcare Offers a 15% Edge as Defensive Growth Meets Deep Value
By stockpickr AI | March 5, 2026 | 10 min read
Investment Summary
Molina Healthcare is a defensive healthcare play that appears slightly undervalued based on current DCF models compared to its historical growth trajectory.
Investment Recommendation
Buy
Fair Value: $352.00
Current Price: $305.65
Upside/Downside: +15.1%
The DCF analysis suggests an upside potential of approximately 15% from current levels based on continued organic enrollment growth. The valuation is supported by a conservative terminal growth rate that accounts for ongoing industry regulatory headwinds.
Key Metrics
- Market Cap: $16.5B
- P/E Ratio: 16.2x
- Forward P/E: 13.5x
- Revenue Growth (YoY): 18.3%
- Net Margin: 2.8%
- ROE: 24.5%
- Debt/Equity: 1.15
- Dividend Yield: 0%
Strengths
- Strong double-digit revenue growth with 2023 revenue reaching approximately $34 billion.
- Proven track record of disciplined acquisitions in the government-sponsored health plan space.
- Robust return on equity (ROE) exceeding 24%, reflecting efficient capital utilization.
- Defensive positioning in the healthcare sector, providing immunity against standard economic cycles.
Risk Factors
- High exposure to government policy changes, specifically Medicaid funding and eligibility redeterminations.
- Rising medical loss ratios impacting net margins, which currently sit at a thin 2.8%.
- Increasing levered balance sheet with long-term debt rising following recent acquisition activity.